O-136. Use of mini-Percoll and swim-up sperm preparation techniques in separating spermatozoa with chromatin packaging anomalies by Bianchi, P.G. et al.
Abstracts of the 13th Annual Meeting of the ESHRE, Edinburgh 1997 
RGD-binding integrins were not involved in the gamete 
fusion process. 
Conclusion: In humans, the surface expression of ~l integrin 
varies during oocyte maturation but its level of expression at 
each of the germinal vesicle, MI and MIl stages is not correlated 
with the extent of gamete fusion. Therefore we suggest that ~l 
integrin participates in the human sperm-egg interaction but is 
not mandatory for fusion. Human gamete fusion may involve 
other co-factors that do not belong to the RGD-binding integrin 
family, but these are still unknown. 
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Introduction: lUI and ovarian stimulation are still extensively 
applied treatment modalities for male sUbfertility. However, the 
efficacy of lUI with or without ovarian stimulation remains a 
matter of debate. Differences found in individual trials have not 
always reached statistical significance. One reason might be the 
lack of power because of the small number of participants. 
Therefore, it seemed appropriate to perform a meta-analysis 
combining the results of available randomized controlled trials 
only. 
Materials and methods: We used the database from the Subfert-
ility Cochrane Centre in combination with three different compu-
terized search programs (Medline, Embase and SClsearch) to 
identify randomized controlled trials. Male subfertility had to 
be the only identifiable cause of subfertility and was defined as 
semen quality not meeting the WHO criteria for normality. Each 
study had to compare the efficacy ofIUI with timed intercourse in 
natural or stimulated cycles or the efficacy of ovarian stimulation 
compared with no stimulation in timed intercourse or lUI cycles. 
The pregnancy rate per completed cycle was the main outcome 
of interest. Two reviewers independently selected all trials, 
assessed the quality of each individual trial and extracted the 
data. Odds ratios (OR) with 95% confidence intervals (CI) were 
calculated for each individual trial and, if appropriate, pooled to 
calculate the overall combined OR. Heterogeneity was tested 
using the Breslow-Day method. 
Results: 
Preliminary results using pooled data from randomized controlled trials 
No. of 
randomized Peto OR 
Comparisons controlled trials (95% CI) 
Natural cycle: IUI versus timed 6 3.05 (1.49---{).27) 
intercourse 
Stimulation cycle: lUI versus timed 6 2.14 (1.30-3.51) 
intercourse 
lUI: stimulation versus natural cycle 4 1.84 (1.01-3.34) 
IUI/stimulation cycle versus timed 2 6.23 (2.35-16.52) 
intercourse/natural cycle 
66 
Conclusion: In male subfertility lUI significantly improves 
the probability of conception in both natural and stimulated 
cycles. Ovarian stimulation seems to improve further the 
efficacy of lUI, although these results should be interpreted with 
care because of the heterogeneity between the different trials. 
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Introduction: The very highly packed nature of human sperm 
chromatin is principally due to dramatic modifications of the 
nucleoprotein components, the most essential consisting of the 
replacement of histones by protamines and further stabilization 
by the formation of disulphide cross-links among the cysteine 
residues of the protamine molecule. The aim of this study was 
to determine the efficiency of the mini-Percoll and swim-up 
sperm preparation techniques to eliminate spermatozoa with 
anomalies in chromatin packaging. 
Materials and methods: Once collected, one portion of the 
semen sample was washed in PBS, fixed using 3:1 methanoll 
acetic acid and spread on a slide. The remainder was prepared 
using the swim-up or mini-Percoll technique. When prepared 
by the swim-up technique, the sediment and upper layer were 
fixed; only the final sperm wash was fixed when using the 
mini-Percoll technique. The spermatozoa were then stained 
using two fluorochromes: monobromobimane (MMBr), which 
indicates the presence of free thiol groups, and chromomycin A3 
(CMA3), which indicates a decreased presence of protamines. 
Hence, good quality spermatozoa would not fluoresce with 
CMA3 or MMBr because they contain a normally protaminated 
chromatin that has been stabilized by disulphide cross-links. 
In all, 30 males were examined using CMA3, while 21 were 
examined using MMBr; 200 spermatozoa were counted on 
each slide. All data were compared using the paired t-test. 
Results: Spermatozoa recovered in the upper layer, when 
prepared using the swim-up technique, showed a significant 
(P < 0.01) increase in MMBr fluorescence compared with the 
fresh sample and with the spermatozoa in the sediment, 
indicating an increase in the number of spermatozoa without 
disulphide cross-links. The percentage of spermatozoa positive 
to the CMA3 fluorochrome did not differ. When spermatozoa 
were prepared using the mini-Percoll technique, the number 
of spermatozoa recovered also showed a significant (P < 0.01) 
increase in MMBr fluorescence compared with the fresh 
sample. In contrast, there was a significant (P < 0.01) decrease 
in CMA3-positive spermatozoa after mini-Percoll preparation 
compared with the fresh sample, indicating that the separation 
method was able to provide more spermatozoa with normally 
protaminated chromatin in the preparation. 
Conclusion: These results indicate that the populations of 
spermatozoa collected after swim-up and mini-Percoll prepara-
tion differ. Neither technique is able to eliminate spermatozoa 
with anomalies in the form of disulphide cross-links. In 
contrast, the mini-Percoll technique can distinguish, and enrich, 
the population of spermatozoa with a more condensed protami-
nated chromatin. 
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cells in patients undergoing IVF with either GnRH 
agonist or GnRH antagonist 
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Introduction: GnRH has a role in regulating gonadotrophin 
release. It has been shown that GnRH may also have a direct 
effect on the ovary because the addition of GnRH to a 
granulosa cell culture inhibits the production of progesterone 
and oestradiol. Specific GnRH receptors have been found to 
be present in rat and human granulosa cells, although the 
function of these receptors is unknown. Desensitization of the 
pituitary by GnRH agonist has become common practice in 
IVF, usually by a long protocol of 2-3 weeks. With the 
introduction of GnRH antagonists, which immediately block 
GnRH receptors, a much shorter period of exposure is needed 
of 3-6 days. The aim of this study was to evaluate the effect 
of the GnRH agonist Buserelin® and the GnRH antagonist 
Cetrorelix® on the function of granulosa cells cultured in vitro 
from IVF patients. 
Materials and methods: Women aged <38 years seeking 
IVF or ICSI treatments were included in this study. They were 
prospectively randomized to have either Buserelin nasal spray 
(150 Ilg four times daily; group 1) from day 21 in the previous 
cycle and for 16 days before ovarian stimulation by 150 lUI 
day HMG, or Cetrorelix (group 2) which started with 150 IV 
HMG on cycle day 2 and 0.25 mg Cetrorelix from day 6 of 
the cycle. HCG was administered when the follicles were> 17 
mm in diameter. Oocytes were aspirated ~36 h later. Granulosa 
cells, separated and washed in EBSS from large follicles 
containing an ovum, were pooled. After 48 h of preincubation 
in Medium 199 (with 1% FBS added), the granulosa cells 
were cultured for 4 days in the above medium supplemented 
with either O.5X 10-5 M testosterone or 1 mM dibutyryl c-
AMP with or without 1 IVlml HCG, with a change of medium 
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after 2 days. The progesterone and oestradiol concentrations 
in the culture medium were measured by an immunological 
assay, and cellular protein by a microprotein assay. 
Results and conclusions: The granulosa cells from the women 
regulated by the GnRH antagonist showed a higher degree of 
steroidogenesis (two to three times) in all cultures (testosterone, 
HCG, c-AMP) than the granulosa cells obtained from the 
women regulated by GnRH agonist. This may be important 
for managing the luteal phase in IVF cycles. 
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Introduction: GnRH released by the hypothalamus potentiates 
the pituitary response to its own action, i.e. the stimulation of 
LH release. This 'self-priming' phenomenon involves the de-
novo synthesis of so-called 'self-priming associated proteins' 
(SPAP). Self-priming is antagonized by a putative ovarian 
hormone, gonadotrophin surge-inhibiting factor (GnSIF), 
which neutralizes the action of SPAP. A number of signal 
transduction pathways converge at the mitogen-activated pro-
tein kinase (MAPK) level. Because MAPK is also activated 
by GnRH, we investigated whether GnSIF interfered with 
GnRH-stimulated LH release upstream or downstream of 
MAPK. In addition, we investigated whether c-AMP was a 
mediator in this action of GnSIF. 
Materials and methods: Mouse gonadotrophic aT3-1 cell 
cultures, or pituitary cells from 28 day old female Wistar rats, 
were seeded in six-well plates (400 000 cells/well) and 
incubated for ~24 h in serum-free medium to reset activated 
MAPK levels (phosphorylated MAPK; MAPK-P) to baseline 
values. The cells were then incubated for 15 min with media 
containing 111M GnRH, highly purified bovine GnSIF prepara-
tions or GnRH with GnSIF added at 0, 5 and 10 min after the 
start of GnRH stimulation. In the homologous aT3-1 cell line, 
GnSIF was also replaced with the non-hydrolysable c-AMP 
analogue 8-Br-c-AMP (3 mM) to mimic c-AMP signalling. 
The cells were lysed in SDS-PAGE loading buffer, and the 
lysates fractionated on 8.5% SDS-polyacrylamide gels. MAPK 
activation was quantitated on Western blots by determining 
the ratio between the MAPK and MAPK-P (migrating 1-2 
kDa higher as MAPK) protein band densities. 
Results: aT3-1 cells showed a 3.5-fold increase in the MAPK-
PIMAPK ratio when stimulated with GnRH. No stimulation 
was found with the GnSIF preparations, and no inhibitory 
effect on GnRH-stimulated MAPK activation was observed. 
When pituitary cells were incubated with GnSIF, no increase 
was seen in the MAPK-PIMAPK ratio. However, in contrast to 
the aT3-1 cells, GnSIF markedly decreased GnRH -stimulated 
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